source Post navigation Pioneering Insights: ERG, Lotus, and GMG Unveil Study on the potential impact of GLP-1 Agonists and Cognitive Health in Diabetes and Obesity – PR Newswire Two type 1 diabetes patients are insulin-free after Eledon's immunosuppressant and an islet transplant – Endpoints News
